NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

Management warrants have been suspended since 2020. I was offered C shares and declined. The criteria for buying are being an accredited investor which includes high net worth individuals, banks, angel investors, or family offices. So anyone that's not a retail investor.

From what I gathered from Les Goldman, the firm are seeking to raise limited capital to get them through the MHRA approval process which I forecast won't be much longer. That aligns with their recent PR which shows they are well on their way towards approval. In my opinion UK approval will occur this year by October.

I suspect the majority of C shares will be used for JV partnership that occurs after UK approval and or journal publication. The firm needs more staff, a CFO, a COO, and funding to launch as many parallel trials as possible. So I believe the JV will be $5-10 billion given the average cost of a clinical trial runs around half a billion dollars. Look at Gilead acquisition of Immunomedics for Trodelvy as a template of what to expect from JV with BP. The stock will be uplisted to NYSE in my opinion when this JV gets executed.

All my personal opinion. Nothing here should be considered investment or legal advice. Do your own research and don't listen to anonymous posts on a message board.

Thank you!